Detalles de la búsqueda
1.
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. / Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper).
Nervenarzt
; 92(8): 773-801, 2021 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-34297142
2.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Mult Scler
; 26(14): 1866-1876, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762387
3.
Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp).
J Med Internet Res
; 21(7): e14373, 2019 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359863
4.
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.
BMC Neurol
; 17(1): 11, 2017 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100182
5.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
Genet Epidemiol
; 39(8): 601-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26497834
6.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
BMC Neurol
; 16: 98, 2016 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27405225
7.
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
Ann Neurol
; 76(6): 792-801, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24729444
8.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Mult Scler
; 21(8): 1036-44, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25392339
9.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
BMC Neurol
; 15: 170, 2015 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26395989
10.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
BMC Neurol
; 13: 117, 2013 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24011220
11.
Status epilepticus and benzodiazepine treatment: Use, underdosing and outcome - insights from a retrospective, multicentre registry.
Seizure
; 107: 114-120, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004393
12.
Prehospital Levetiracetam Use in Adults With Status Epilepticus: Results of a Multicenter Registry.
J Clin Neurol
; 19(4): 365-370, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417432
13.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Mult Scler
; 18(3): 314-21, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21878455
14.
Oral triptans in the preventive management of cluster headache.
Curr Pain Headache Rep
; 16(2): 180-4, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22382758
15.
Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon ß-1b: Observational Study.
JMIR Form Res
; 6(3): e31972, 2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285806
16.
Correction: Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon ß-1b: Observational Study.
JMIR Form Res
; 6(3): e38002, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298393
17.
Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry.
J Neurol
; 269(11): 5710-5719, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802201
18.
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
BMJ Open
; 12(1): e049300, 2022 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078833
19.
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design.
Headache
; 51(1): 129-34, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21198573
20.
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years.
Mult Scler Relat Disord
; 49: 102717, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476880